Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders
28 juin 2022 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Sleep Tech Devices Market to cross USD 67 billion by 2030, says Global Market Insights Inc.
25 mai 2022 03h17 HE
|
Global Market Insights Inc.
Selbyville, Delaware, May 25, 2022 (GLOBE NEWSWIRE) -- The sleep tech devices market value is expected to reach USD 67 billion by 2030, according to a new research report by Global Market Insights...
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
13 mai 2022 08h30 HE
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR
12 mai 2022 08h30 HE
|
Vallon Pharmaceuticals Inc.
PHILADELPHIA, PA, May 12, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
Sleep Disorder Market revenue to cross USD 20.5 Bn by 2027: Global Market Insights Inc.
12 janv. 2022 06h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The sleep disorder market size is anticipated to record a valuation of USD 20.5 billion by 2027, according to the most recent study by...
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
08 nov. 2021 07h00 HE
|
Axsome Therapeutics, Inc.
Company to host conference call today at 8:00 AM Eastern NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies...
Global Narcolepsy Drugs Market Size to Hit $6.66 Billion by 2030: Allied Market Research
05 oct. 2021 10h11 HE
|
Allied Market Research
Portland, OR, Oct. 05, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Narcolepsy Drugs Market was worth $2.68 billion in 2020, and is projected to...
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
16 sept. 2021 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS)...
Narcolepsy Market Growth Sturdy at 9.5% CAGR to Outstrip $4,537.9 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
18 mai 2021 19h25 HE
|
The Insight Partners
Pune, India., May 19, 2021 (GLOBE NEWSWIRE) -- Narcolepsy Market: Key InsightsAccording to our new research study on “Narcolepsy Market to 2027 – Global Analysis and Forecast – by Type, Product, and...
Sleep Tech Devices Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
10 mai 2021 06h00 HE
|
Graphical Research
Pune, India, May 10, 2021 (GLOBE NEWSWIRE) -- The global sleep tech devices market size is predicted to show tremendous growth during the forecast period owing to the growing need among...